The HPV16 oncogenes cause aberrant stem cell mobilization  by Michael, Stella et al.
Virology 443 (2013) 218–225Contents lists available at SciVerse ScienceDirectVirology0042-68
http://d
n Corr
tory, Un
E-mjournal homepage: www.elsevier.com/locate/yviroThe HPV16 oncogenes cause aberrant stem cell mobilization
Stella Michael a, Paul F. Lambert b, Katerina Strati a,n
a Department of Biological Sciences, University of Cyprus, 1 University Ave., Nicosia 2109, Cyprus
b Department of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin, School of Medicine and Public Health, 1400 University Ave.,
Madison, WI 53706, USAa r t i c l e i n f o
Article history:
Received 12 February 2013
Returned to author for revisions
13 March 2013
Accepted 11 April 2013
Available online 8 May 2013
Keywords:
HPV
E6
E7
Stem cells22/$ - see front matter & 2013 Elsevier Inc. A
x.doi.org/10.1016/j.virol.2013.04.008
espondence to: Department of Biological Scie
iversity of Cyprus, 1 University Ave., Nicosia 2
ail address: strati.katerina@ucy.ac.cy (K. Stratia b s t r a c t
Human Papilloma Virus related epithelial cancers have been speculated to derive from virus-infected tissue
stem cells. Stem cells also are thought to provide a reservoir of latently infected cells that can persist for long
periods. In this study we have examined the effects of HPV16 E6 and E7 oncogenes on multipotent epithelial
stem cells, using in vivo systems. Our results show that expression of HPV16 oncogenes reduces the number
of bulge label-retaining cells within hair follicles at telogen suggesting aberrant mobilization, a result
supported by increased mobilization upon acute anagen induction. Importantly the loss of relative
quiescence, a hallmark feature of stem cells, occurs in the absence of a reduction in other stem cell markers.
This points to an atypical stem cell compartment in the context of E6 and E7 expression. We hypothesize that
this aberrant compartment may have important roles in the viral life cycle and/or ensuing carcinogenesis.
& 2013 Elsevier Inc. All rights reserved.Introduction
A growing body of literature supports the notion that infectious
agents perturb stem cell homeostasis in target tissues (Pitsouli et al.,
2009). For pathogens that complete their life cycle inside the cell,
such as viruses, changes in tissue stem cell homeostasis could have
profound effects on infection outcome. This host–pathogen interac-
tion is particularly interesting in cases where infection is associated
with carcinogenesis, where aberrant stem cell homeostasis could be
related to ensuing carcinogenesis. Cervical carcinomas have long
been hypothesized to arise from cervical stem cells, but there is a
scarcity of publications addressing the interplay of the viral onco-
genes with tissue stem cells.
Human papillomaviral infections speciﬁcally arise in stratiﬁed
squamous epithelia such as those lining the skin, the anogenital tract
and oral epithelia and, in the context of high risk HPV infections, leads
to the development of a number of cancers including cervical, anal, as
well as head and neck cancers. The two most important papilloma-
viral oncogenes, E6 and E7, not only are necessary for the viral life
cycle but also for the development as well as the persistence of HPV-
associated cancers (Goodwin and DiMaio, 2000; Jabbar et al., 2009).
Papilloma virus infections are thought to arise through infection of
cells within the basal layer of stratiﬁed squamous epithelia, which is
the layer of cells that makes direct contact with the basement
membrane and constitutes the proliferative compartment of these
epithelia (Kines et al., 2009). A limited body of evidence supports the
notion that papillomaviruses infect cells with stem-like characteristicsll rights reserved.
nces, Tumor Viruses Labora-
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).(Schmitt et al., 1996) but the consequences of viral oncogene
expression in tissue stem cells in vivo are largely unknown. Further-
more, it has been proposed that tissue stem cells are the sites of
persistent infection by the virus (Maglennon et al., 2011). In the
cervix, the most common site of HPV16 infection, cancers are thought
to arise from the transition zone between glandular and squamous
epithelia where stem-like cells are thought to reside. It is therefore
evident that stem cells are a potential direct target of infectious
agents and, in accordance with studies indicating that some cancers
derive from tissue stem cells, this may have an important role in
carcinogenesis. However, it is still not clear whether HPV, or other
similar cancer causing viruses, directly affects the development,
function, or plasticity of tissue stem cells.
A clear challenge in assessing the consequences of viral
oncogene expression in cervical tissue stem cells is the lack of
well-characterized markers that would enable their successful
detection as well as functional assays for tissue stem cells. An
alternative model, which has been extensively used to study HPV
infection and biology, is the skin (Auewarakul et al., 1994;
Lambert et al., 1993; Merrick et al., 1992). The stem cell compart-
ments of the mouse skin have been extensively characterized and
various populations with “stemness characteristics” have now
been described. The best understood stem cell population lies in
the skin hair follicle, in a niche dubbed the “bulge”. This is a
population that, like many other tissue stem cells, is relatively
quiescent and the identiﬁcation of its slow-cycling nature and
label retaining ability dates back to 1990 (Cotsarelis et al., 1990).
The nucleotide pulse-chase technique has been extensively used
for the detection of the bulge population and led to its identiﬁca-
tion as a stem cell population and its contribution not only to hair
follicle regeneration in vivo, but also to interfollicular epidermal
skin healing after wounding (i.e. this is a multipotent tissue stem
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et al., 2004; Zhang et al., 2009). In addition to the pulse-chase
technique, a marker used to genetically target bulge cells for
lineage-tracing analysis is cytokeratin 15 (K15), which allows for
labeling of the bulge and secondary hair germ regions (Liu et al.,
2003; Lyle et al., 1998; Morris et al., 2004).
Contributing to the choice of using the skin tissue as a model
is also the fact that it undergoes homeostasis resulting in the highly
ordered process of hair follicle growth, which consists of cycles of
growth and regression. In these cycles, a subset of bulge stem cells
have been shown to mobilize out of their niche during the growth
phase, known as anagen or stem cell mobilization, migrate to lower
regions of the hair bulb where they proliferate and differentiate
contributing to the formation of new hair (Blanpain and Fuchs,
2006). This stem cell model has been widely used to determine the
implication of stem cells in carcinogenesis and it should be noted that
several lines of evidence implicate the bulge stem cells speciﬁcally, as
the cells of origin in squamous cell carcinomas (Lapouge et al., 2011).
To elucidate the role of viral oncogenes in modulating the behavior
of quiescent tissue stem cells, we used transgenic animals expressing
the viral oncogenes E6 and E7 of HPV16 in stratiﬁed squamous
epithelia. Focusing speciﬁcally in the hair follicle bulge stem cells we
describe here that, while the overall numbers of bulge stem cells do
not appear to be reduced upon E6 and E7 expression, their ability to
remain quiescent and thus retain label, is compromised, and their
ability to proliferate upon anagenic stimuli is enhanced. A potential
modulation of tissue stem cell mobilization may have important
implications on infection outcome, including eventual carcinogenesis.
Results
Expression of the HPV16 oncogenes reduces the number of relatively
quiescent cells detected at telogen
K14E6 and K14E7 mice have been previously generated and
extensively characterized (Herber et al., 1996; Song et al., 1999).Fig. 1. Expression of the HPV16 oncogenes leads to reduced detection of LRCs in hai
shortly after birth and chased until second telogen. ∼50 Hair follicles were selected from
BrdUrd positive cells per hair follicle bulge was quantiﬁed and plotted for each genotype
Wilcoxon rank sum test. (B) Representative immunoﬂuorescent ﬁgures of hair follicles s
(blue).The keratin 14 promoter directs expression of the HPV16 onco-
genes to the basal layer of stratiﬁed epithelia, including the bulge
niche (Arbeit et al., 1994). In order to assess the effects of E6 and
E7 expression in quiescent bulge stem cells, BrdU pulse-chase
assays were performed as previously described (Cotsarelis et al.,
1990; Bickenbach et al., 1986; Morris and Potten, 1999), and the
numbers of label-retaining cells (LRCs) at second telogen (resting
phase of hair cycle) were compared in wild type animals and
animals transgenic for either one or both of the oncogenes
(Fig. 1A). The numbers of LRCs were signiﬁcantly reduced in mice
expressing either one of the two, or both viral oncogenes suggest-
ing either an overall reduction in the numbers of this particular
stem cell type or enhanced proliferation, which could lead to a
more rapid label loss.
Stem cells expressing the HPV16 oncogenes have increased
mobilization upon acute anagen induction
In order to further investigate the proliferation potential of
stem cells expressing viral oncogenes, anagen was acutely
induced. A pulse-chase protocol was performed as above and
anagen was induced by repeated TPA administration prior to
harvesting. Successful anagen induction was validated by the
characteristic hair follicle elongation in all genotypes examined
(Fig. 2A and B). Hair elongation was also observed in follicles
expressing the HPV16 oncogenes under resting conditions.
LRC mobilization was monitored as a function of BrdU label loss
by means of BrdU-speciﬁc immunohistochemistry. In animals
expressing E6, E7 or both oncogenes mobilization of stem cells
was more pronounced compared to that seen in wild type animals
(Fig. 2C) suggesting that HPV oncogene expression can lead to a
higher level of basal proliferation, or even precocious anagen even
in the absence of external anagenic stimuli. This result suggests
that tissue stem cells expressing E6 or E7 are more poised to
proliferate, explaining in part the reduced numbers of LRCs
detected in telogen conditions (Fig. 1).r follicle bulge at telogen. (A) LRCs were labeled using a BrdU pulse administered
at least 3 mice of each genotype, NTG, E6, E7 and E6E7 mice. The mean number of
(columns); bars, SD. All statistical comparisons were performed using a two-sided
howing BrdU positive cells (red–white arrow). Counterstaining was done with DAPI
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Fig. 2. Expression of the HPV16 oncogenes leads to more rapid mobilization of LRCs in response to acute anagen induction. (A) In order to induce anagen in mice
where LRCs were labeled, TPA was applied on mice every 48 h for four times. H&E staining was performed on all tail hair follicles. Hair follicle length was quantiﬁed to verify
effective anagen induction. (B) ∼70 Hair follicles were selected from at least 3 mice of each genotype, NTG, E6, E7 and E6E7 mice. The mean hair follicle length in μm was
measured and plotted for each genotype (columns); bars, SD. All statistical comparisons were performed using a two-sided Wilcoxon rank sum test. Statistical signiﬁcance
was also observed between NTG and transgenic mice under resting (no TPA) conditions. (C) In order to track the mobilization of LRCs in response to acute anagen induction,
the percentage reduction of LRCs was tracked per genotype. At least 3 mice of each genotype at anagen (TPA) and telogen (no TPA), NTG, E6, E7 and E6E7 mice, were selected
and hair follicle bulge regions were quantiﬁed. The relative reduction of BrdUrd positive cells per hair follicle bulge was plotted for each genotype (columns); bars, SD. All
statistical comparisons were performed using a two-sided Wilcoxon rank sum test. Statistical signiﬁcance was also observed between E6 and E6E7 mice.
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robust proliferative ability in hair follicles
To investigate LRC mobilization outcome, hair re-growth was
monitored. The backs of transgenic and control mice were shaved
at day 65, previously characterized to correspond to the end of
second telogen. Hair re-growth was monitored for up to 8 days
post-shaving and was enhanced in mice expressing both E6 and E7
(Fig. 3A). Complete hair re-growth, consistent with increased
tissue stem cell activity in those animals was only evident in mice
bitransgenic for both E6 and E7. Also consistent with that result a
greater increase in PCNA staining in anagen hair follicles from the
bitransgenic animals was seen (Fig. 3B and C).
HPV16 oncogene expression does not lead to an overall reduction of
other bulge stem cell markers
In order to eliminate the possibility that reduced LRC numbers
(Fig. 1) are indicative of aberrant reduction in numbers of stem cells,
endogenous markers of bulge stem cells, such as the expression of
K15 was tested (Liu et al., 2003). The results showed an increase in
the numbers of K15 positive cells and thus expansion of the K15 layer
in both conditions of telogen and anagen (Fig. 4A and B). Thus, the
reduction in LRC numbers is not consistent with an overall decreasein stem cell markers. On the contrary, an aberrant expansion in the
K15 compartment is detected, suggesting that an increased ability to
proliferate might not be the only change induced in stem cells by E6
and E7 expression.The Nfatc1 pathway is perturbed upon viral oncogene expression
In order to test whether the quiescence of bulge stem cells is
affected by oncogene expression, the nuclear localization of the
Nuclear factor of activated T-cells (Nfatc1), shown to be the gate-
keeper of bulge stem cell quiescence, was tested in both telogen and
anagen conditions (Horsley et al., 2008). No signiﬁcant changes were
observed in nuclear localization in conditions of follicle growth when
the oncogenes were expressed (Fig. 5B). However, under resting
conditions the expression of E6 or both E6 and E7 led to a signiﬁcant
reduction in the numbers of stem cells with nuclear Nfatc1 (expres-
sion of E7 alone did not have the same result, in fact it led to a
signiﬁcant increase of nuclear Nfatc1) (Fig. 5A). Furthermore, the
expression of Cdk4, a downstream target of Nfatc1 and also a cell
cycle gene implicated in the Rb pathway was tested showing an
increase in both telogen and anagen conditions when the oncogenes
are expressed (Fig. 5C and D).
Fig. 3. Increased mobilization of LRCs correlates with increased hair growth in mice expressing the HPV16 E6 and E7 oncogenes. (A) Backs of telogen mice of all
genotypes were shaved and pictures were taken at days 0 and 8 after shaving. (B) ∼50 Hair follicles were selected from at least 3 mice of each genotype, NTG, E6, E7 and E6E7
mice. The mean number of PCNA positive cells at the base of each hair follicle was quantiﬁed and plotted for each genotype (columns); bars, SD. All statistical comparisons
were performed using a two-sided Wilcoxon rank sum test. (C) Representative immunoﬂuorescent ﬁgures of hair follicles showing PCNA positive cells (red). Counterstaining
was done with DAPI (blue).
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Tissue stem cells have been implicated as the cells of origin in
several cancer types. In the case of cervical cancers, they have been
proposed to derive from multipotent cervical progenitors because
tissue stem cells provide a reservoir of latently infected cells that
support the viral life cycle (Maglennon et al., 2011), or because of
differential infection or infection outcome in these types of cells.
Despite the sustained interest around this topic i.e. the cell of
origin in cancers, very little work addressing the expression of
viral oncogenes in tissue stem cells has been done, mostly due to
lack of understanding of what constitutes a true cervicalmultipotent cell, even though the prevailing dogma suggests that
these reside in the so-called transformation zone. We have chosen
the quiescent epithelial stem cells found in the hair follicle bulge
region to assess the effects of E6 and E7 expression in vivo because
this stem cell population is well-characterized. We propose that
the expression of viral oncogenes in tissue stem cells promotes
aberrant mobilization consistent with an improved ability of these
cells to repopulate the tissue and possible roles in cancer
initiation.
Two recent publications propose an alternate hypothesis to
tissue stem cells as the cells of origin in cancers. These authors
suggest that speciﬁc cell subpopulations of embryonic origin are
Fig. 4. Other markers of bulge stem cells are not reduced in response to HPV16 oncogene expression. (A) Immunoﬂuorescence was performed using a K15-speciﬁc
antibody. ∼50 Hair follicles were selected from at least 3 mice of each genotype, NTG, E6, E7 and E6E7 mice. The mean number of K15 positive cells of each hair follicle was
quantiﬁed and plotted for each genotype (columns); bars, SD. All statistical comparisons were performed using a two-sided Wilcoxon rank sum test. Statistical signiﬁcance
was also observed between the NTG and the transgenic mice (no TPA) as well as between the various transgenics (TPA-treated). (B) Representative immunoﬂuorescence of
K15 staining (red) in the hair follicles of the genotypes examined. Counterstaining was done with DAPI (blue).
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lesions including some cervical malignancies (Herfs et al., 2012;
Wang et al., 2011). This is due, at least in part, to the ability of these
cells to outcompete neighboring populations in situations of tissue
insult such as HPV infection. Of course, the proposed mechanism,
and the traditionally held view that at least some cancers may be
derived from the transformation zone are not mutually exclusive.
The exact role of these squamocolumnar populations during
normal tissue homeostasis is not known, nor is it known whether
this anatomic location harbors cells with stem-like characteristics.
In either case, our results support the notion that speciﬁc cell
subpopulations which express the HPV16 oncogenes are more
poised to repopulate the tissue, consistent with the cell-
competition theory proposed.
In this study, we observed that expression of E6 and E7, the
main viral oncogenes of HPV16, can compromise the relative
quiescence of epidermal stem cells and lead hair follicles to
precocious anagen entry as seen by the reduction in LRC numbers
in both telogen and acute anagen conditions (Figs. 1 and 2C). This
demonstration of disruption speciﬁcally of quiescent tissue stem
cell homeostasis in vivo represents a novel phenotype associated
with the expression of these oncogenes. Another recent study
focusing on the effects of all HPV16 genes in non-quiescent
populations of the hair follicle conﬁrmed our ﬁndings (da Silva-
Diz et al., in press). While the reduction in LRCs is a direct measure
of proliferation in relatively quiescent populations which tracks
the loss of label, staining for PCNA correlates to a great extent but
not fully. The reason for this is that PCNA staining reﬂects thecumulative proliferation in the hair follicle including that derived
from other populations.
To further verify that a reduction in LRCs is not indicative of a
reduction in tissue stem cells overall, we characterized the
expression of other stem cell markers. Expression of other stem
cell markers such as K15 is not reduced in the presence of the
oncogenes diminishing the possibility that the results seen are the
result of reduced stem cell numbers (Fig. 4A). In contrast, there is
an expansion of the K15 layer in both telogen and anagen
conditions which might indicate the expansion of an aberrant
population which shares some but not all stem cell characteristics.
The expression of other proposed stem cell markers such as Lgr5
and Lgr6 (Jaks et al., 2008; Snippert et al., 2010), were tested by
immunoﬂuorescence but results were inconclusive.
In an attempt to explain the reduction in the LRC numbers,
the nuclear localization of the quiescence marker Nfatc1 was also
tested (Fig. 5). The results showed that the quiescence of the
follicle cells can be compromised in resting conditions when E6 is
expressed suggesting that the Nfatc1 pathway could be a possible
direct or indirect target of the oncogene. Surprisingly, the number
of Nfatc1 positive cells in hair follicles expressing E7 only was
higher, despite all other evidence contrary to quiescence. Further-
more, in some cases (Fig. 5B and D) we observe an uncoupling of
the expected relationship between the detection of nuclear Nfatc1
and its downstream target CDK4. This leads us to the conclusion
that while under normal conditions anagen induction is marked
by loss of nuclear Nfatc1, forced anagen induction need not occur
by direct action on Nfatc1 but may in fact be marked by
Fig. 5. The quiescence of the bulge stem cell population is affected upstream as well as downstream of the Nfatc1 pathway by HPV16 oncogene expression. (A–D) ∼50
Hair follicles were selected from at least 3 mice of each genotype, NTG, E6, E7 and E6E7 mice. The mean number of Nfatc1 (A,B) and Cdk4 (C,D) positive cells of each hair
follicle in telogen (no TPA) (A,C) and anagen (TPA) (B,D) conditions was quantiﬁed and plotted for each genotype (columns); bars, SD. All statistical comparisons were
performed using a two-sided Wilcoxon rank sum test. (E,F) Representative immunoﬂuorescense staining of (E) nuclear Nfatc1 and (F) Cdk4 positive cells is depicted by
arrows. Counterstaining was done with DAPI (blue).
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CDK4 is actually a more reliable marker of the balance between
proliferation and quiescence. The expression of Cdk4, a down-
stream target of Nfatc1 and also a cell cycle regulatory gene
involved in Rb homeostasis, increased both in the resting telogen
and anagen conditions when E7 or both oncogenes are expressed(when E6 only is expressed the increase is statistically signiﬁcant
only in anagenic conditions) (Fig. 5C and D). The lack of exact
correlation between the Nfatc1 and Cdk4 results in the E6 and E7
transgenic animals may suggest that E6 and E7 are affecting
cellular quiescence in independent ways. For example it is more
likely, that at least in resting conditions E7 is affecting factors
S. Michael et al. / Virology 443 (2013) 218–225224downstream of Nfatc1 including Cdk4 which could be targeted
directly (Fig. 5A and C). The increase in Nfatc1 positive cells in
E7-expressing hair follicles may represent a yet-to be described
compensation mechanism.
Our results indicate that relative quiescence and K15 are indepen-
dent determinants of stemness and appear to be differentially
regulated by the HPV oncogenes. We speculate that E6 and E7 may
lead to cellular reprogramming giving rise to an aberrant stem-like
population that is not relatively quiescent but expresses somemarkers
of stemness such as K15. Future studies may shed some light on this
interesting possibility.
Our work shows that the proliferation defects seen apply
speciﬁcally to the quiescent label retaining cells and can be
attributed to the viral oncogenes. Moreover, both oncogenes seem
to be contributing to this phenotype, consistent with an important
role for both in the context of carcinogenesis. Furthermore, the
aberrant expansion of other markers of stem cells supports the
development of an aberrant stem cell compartment, in the pre-
sence of HPV oncogenes, capable of enhanced proliferation.
The relevant cellular targets of E6 and E7 that are associated with
this phenotype are not known, however, both E6 and E7 have the
ability to modulate the function of cellular targets implicated in tissue
stem cell biology. These include telomerase, pRb, E2F6 and polycomb
group complexes and also histone demethylases. E6 can upregulate
telomerase activity by intricate regulation at the transcriptional and
posttranscriptional level (Liu et al., 2009). It has been shown that
increased telomerase expression in the progenitor cell niche leads to
quantitative and functional changes in this compartment (Flores et al.,
2005; Sarin et al., 2005). The same applies for E7, whose prominent
target pRb has also been shown to directly affect the progenitor cell
niche (Ruiz et al., 2004). In conditional knockouts for RB, a parallel to
the degradation seen by E7 expression, the LRCs of the skin are shown
to be decreased. Furthermore, E7 has been shown to interact with
E2F6 and in part inhibit its association with polycomb group com-
plexes, which are crucial to cell fate decisions (McLaughlin-Drubin
et al., 2008). These complexes can also be inhibited from binding to
histone 3 by induction of histone demethylases KDM6A and KDM6B
in E7 expressing cells (McLaughlin-Drubin et al., 2011).
To conclude, this study reveals the ability of the virus to modulate
stem cells which could be crucial to their ability to contribute to
carcinogenesis since these types of cells were shown to be the cells of
origin in epithelial cancers. The enhanced ability of stem cells express-
ing HPV oncogenes to proliferate could put them in a better position to
repopulate wounded tissue at the expense of non-infected cells.
Continuous repopulation of tissue by cells expressing the oncogenes
may be linked to ensuing carcinogenesis. Further studies to identify
the exact molecular targets and pathways that are affected in the
presence of the viral oncogenes could aid in the better understanding
of stem cell homeostasis in the context of viral infection.Materials and methods
Mice
Mouse strains were generated in the lab of Dr. Paul Lambert
(University of Wisconsin, Madison). The mice used in the experiments
were kept on a pure FVB/N inbred genetic background and were
K14E6/E7TTL referred to as K14E6 or E6 and K14E7/E6TTL referred to
K14E7 or E7 as previously described (Herber et al., 1996; Song et al.,
1999). For the generation of bitransgenic mice K14E6 were crossed
with K14E7 and the genotypes were conﬁrmed by means of PCR. All
the experimental mice used were in a heterozygous state. Mice were
housed at the University of Cyprus, in accordance with regulations
and protocols approved by the Cyprus Ministry of Agriculture.BrdU incorporation, anagen induction and hair shaving
5-Bromo-2-deoxyuridine (BrdU) was administered peritoneally
in mice at a ﬁnal concentration of 50 mg/kg as ﬁrst described
previously (Bickenbach et al., 1986; Cotsarelis et al., 1990). For
pulse chase experiments ten-day-old mice received an injection
every 12 h for a total of four doses and they were euthanised 60
days after injections. For induction of anagen in age-matched
mice, at day 60 after BrdU injection, hair was shaved and mice
were treated every 48 h with TPA (20 nmol in acetone) for a total
of four doses.
Immunohistochemistry
Mice were sacriﬁced, and tissues obtained were ﬁxed in 4%
paraformaldehyde overnight at 4 1C. Dehydration of the samples
was performed in a graded series of ethanol concentrations and
xylene before they were embedded in parafﬁn wax. Sections were
obtained at 10 mm thickness on a microtome and left overnight to
dry at room temperature. Samples were deparafﬁnised in xylene
and rehydrated in a graded series of ethanol solutions. Antigen
retrieval was done in a microwave using 10 mM citrate buffer and
for BrdU immunohistochemistry, samples were also incubated for
20 mins in 2 M HCl. Blocking and antibody incubations were
variable and optimal for each different antibody used. Primary
antibodies used include: BrdU (Abcam), K15 (SantaCruz), Nfatc1
(SantaCruz), PCNA (SantaCruz). Following primary antibody incu-
bation samples were washed in PBS. The following secondary
antibodies were used: FITC-rabbit, Cy3-rat, Cy3-mouse, Cy3-
streptavidin and biotin-rat all from Jackson ImmunoResearch and
also Vectastain universal secondary (Vector laboratories). All
images were acquired using a Zeiss Axio Observer.A1 microscope.
Quantiﬁcation was performed in a blinded fashion.
Statistical tests
To determine the statistical signiﬁcance between the genotypes
in each experiment, 3 mice of each genotype were used and 50–70
hair follicles were counted. Statistical analysis was done using
“Mstat” software (version 5.5.3, McArdle Laboratory for Cancer
Research, University of Wisconsin–Madison [http://mcardle.oncol
ogy.wisc.edu/mstat/]). Results were compared using a Wilcoxon
rank sum test. For all statistical tests differences were considered
statistically signiﬁcant at p≤0.05.Acknowledgments
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